Evidence map›Paper›PMID 31496351›Full record

ArticleCell cycle (Georgetown, Tex.)2019

Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-κB signaling in macrophages.

Zhujun An, Jiawen Li, Jiangbo Yu, Xiaoli Wang, Hailai Gao, Wei Zhang, Zeren Wei, Jianchun Zhang, Yinli Zhang, Jiyi Zhao and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 2 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 2 syntheses or guidelines pooled it, 254 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Cellular senescence and aging: molecular mechanisms and convergent pathways.Cellular and molecular life sciences : CMLS · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A pathology-to-single-cell framework links SPP1Journal of translational medicine · 2026
    Article
  20. Review

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Zhujun AnDepartment of ICU, Harbin Red Cross Center Hospital , Harbin , Heilongjiang , China.
Jiawen LiDepartment of Cardiovascular, The Fourth Affiliated Hospital of Harbin Medical University , Harbin , Heilongjiang , China.
Jiangbo YuDepartment of Cardiovascular, The First Affiliated Hospital of Harbin Medical University , Harbin , Heilongjiang , China.
Xiaoli WangDepartment of Pneumology, Qingdao Women and Children's Hospital , Qingdao , Shandong , China.
Hailai GaoDepartment of Cardiovascular, The First Hospital of Harbin , Harbin , Heilongjiang , China.
Wei ZhangDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Harbin Medical University , Harbin , Heilongjiang , China.
Zeren WeiDepartment of Cardiovascular, The First Affiliated Hospital of Harbin Medical University , Harbin , Heilongjiang , China.
Jianchun ZhangDepartment of Cardiovascular, The First Affiliated Hospital of Harbin Medical University , Harbin , Heilongjiang , China.
Yinli ZhangDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University , Harbin , Heilongjiang , China.
Jiyi ZhaoDepartment of Cardiovascular, The First Affiliated Hospital of Harbin Medical University , Harbin , Heilongjiang , China.
Xiao LiangDepartment of Cardiovascular, The First Affiliated Hospital of Harbin Medical University , Harbin , Heilongjiang , China.
First Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNFourth Affiliated Hospital of Harbin Medical University · CNQingdao Women and Children's Hospital · CNThe First Hospital of Kunming · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we sought to explore the underlying role of interleukin (IL)-8 in neutrophil extracellular traps (NETs) formation during atherosclerosis (AS). The concentration of pro-inflammatory cytokines IL-8, IL-6 and IL-1β was determined by enzyme-linked immunosorbent assay (ELISA). NETs formation was evaluated by immunofluorescence and myeloperoxidase (MPO)-DNA complex ELISA. The mRNA levels of IL-8 and Toll-like receptor 9 (TLR9) were measured by quantitative real-time PCR (qRT-PCR). The phosphorylation levels of NF-κB p65 were detected by western blotting. The hematoxylin and eosin (H&E) staining of atherosclerotic lesion areas was performed in ApoE-deficiency mice. Results showed that patients with AS showed higher serum levels of IL-8, a pro-inflammatory cytokine and NETs. IL-8 interacted with its receptor CXC chemokine receptor 2 (CXCR2) on neutrophils, leading to the formation of NETs via Src and extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinases (MAPK) signaling to aggravate AS progression

Indexed as

AnimalsAtherosclerosisCell Line, TumorEnzyme-Linked Immunosorbent AssayExtracellular Signal-Regulated MAP KinasesExtracellular TrapsGene Expression RegulationHumansInterleukin-1betaInterleukin-6Interleukin-8MacrophagesMiceMice, Inbred C57BLMice, KnockoutNeutrophilsCXCL8 protein, humanCXCR2 protein, humanExtracellular Signal-Regulated MAP KinasesIL1B protein, humanIL6 protein, humanInterleukin-1betaInterleukin-6Interleukin-8p38 Mitogen-Activated Protein KinasesReceptors, Interleukin-8BRELA protein, humanTLR9 protein, humanToll-Like Receptor 9Transcription Factor RelAAtherosclerosisIL-8macrophagesneutrophil extracellular traps

Identifiers

PMID31496351
PMCPMC6791689
OpenAlexW2973061425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.